Eade K, Gantner M, Hostyk J, Nagasaki T, Giles S, Fallon R, et al. Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease. Nat Metab. 2021;3:366-377 pubmed publisher

Białopiotrowicz E, Noyszewska Kania M, Kachamakova Trojanowska N, Łoboda A, Cybulska M, Grochowska A, et al. Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells. Cancers (Basel). 2020;12: pubmed publisher

Dalton W, Helmenstine E, Walsh N, Gondek L, Kelkar D, Read A, et al. Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation. J Clin Invest. 2019;130:4708-4723 pubmed publisher

Yoshino H, Nohata N, Miyamoto K, Yonemori M, Sakaguchi T, Sugita S, et al. PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2?-Targeting Therapy for Renal Cell Carcinoma. Cancer Res. 2017;77:6321-6329 pubmed publisher

Pacold M, Brimacombe K, Chan S, Rohde J, Lewis C, Swier L, et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol. 2016;12:452-8 pubmed publisher